Your session is about to expire
← Back to Search
Open-Label Placebo for Spinal Cord Injury Opioid Management
Study Summary
This trial will study if using a conditioning open-label placebo can help reduce opioid dosage for patients with spinal cord injury, polytrauma, and burn injury, in order to reduce side effects and the risk of addiction.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 3 trial • 465 Patients • NCT01316380Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have moderate to severe pain from nerve damage or injury.I am 18 or older with a spinal cord injury or severe burn from Spaulding Rehabilitation.I use no more than 120 mg of morphine or its equivalent.I have a history of bipolar disorder or psychosis.I have a serious health condition that could affect my safety in the study.My breathing and heart functions are stable.I am taking a high dose of pain medication.I have multiple injuries or have had surgery for burns, amputations, or bone issues.I am a patient from Spaulding with SCI, polytrauma, or burns, and my pain started less than 5 years ago.
- Group 1: Treatment as usual
- Group 2: Conditioning Open-Label Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the sample size for this clinical experiment?
"Indeed, the information on clinicaltrials.gov illustrates that this trial is presently searching for patient volunteers. It was initially posted on August 3rd 2022 and modified lastly on October 25th 2022. 66 participants are required from 1 medical centre to complete the study."
Is there availability for enrolment in this clinical investigation?
"This medical trial is actively seeking patients, as indicated on clinicaltrials.gov. It was initially posted on August 3rd 2022 and updated for the last time 25th October of that same year."
Share this study with friends
Copy Link
Messenger